Literature DB >> 6818039

Effects of oral chlordemethyldiazepam on plasma adrenaline and noradrenaline and cardiovascular reactivity in preoperative patients.

G B Picotti, O Corli, M D Galva, G P Bondiolotti, M O Carruba.   

Abstract

In 11 preoperative women, plasma adrenaline (A) concentrations were lower after oral administration of an antianxiety dose (19.25 micrograms/kg) of chlordemethyldiazepam (Cl-DMDZ) than the predrug values, or those in 12 patients given placebo. No significant differences in supine plasma noradrenaline (NA), blood pressure (BP) and heart rate values were observed. Digital plethysmography showed finger vasoconstriction after placebo and vasodilatation after Cl-DMDZ. A mental arithmetic test caused equivalent rises in plasma A in both groups. Standing caused plasma NA to rise to similar levels in both groups of patients, but the BP decrease was less and there was a markedly lower incidence of orthostatic hypotension in the Cl-DMDZ treated group. It is concluded that the effect of Cl-DMDZ on the release of catecholamines from the peripheral sympathetic system consists essentially of decreasing basal adrenomedullary activity. CL-DMDZ appears to prevent the orthostatic hypotension which occurs when neurosympathetic reflex activation is normal.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818039     DOI: 10.1007/bf00605986

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

Review 1.  Systemic arterial baroreceptor reflexes.

Authors:  H R Kirchheim
Journal:  Physiol Rev       Date:  1976-01       Impact factor: 37.312

Review 2.  Molecular mechanisms in the receptor action of benzodiazepines.

Authors:  E Costa; A Guidotti
Journal:  Annu Rev Pharmacol Toxicol       Date:  1979       Impact factor: 13.820

3.  The effects of oral sedatives on the vasoconstrictive reaction to fear.

Authors:  M Johnstone
Journal:  Br J Anaesth       Date:  1971-04       Impact factor: 9.166

4.  Effects of central GABA receptor agonism and antagonism on evoked diencephalic cardiovascular responses.

Authors:  M J Antonaccio; L Kerwin; D G Taylor
Journal:  Neuropharmacology       Date:  1978-08       Impact factor: 5.250

5.  Plasma levels of norepinephrine.

Authors:  I J Kopin; R C Lake; M Ziegler
Journal:  Ann Intern Med       Date:  1978-05       Impact factor: 25.391

6.  Counteraction of circulatory side effects of ketamine by pretreatment with diazepam.

Authors:  E K Zsigmond; S P Kothary; S M Kumar; R C Kelsch
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

7.  Picrotoxin- and bicuculline-sensitive inhibition of cardiac vagal reflexes.

Authors:  S M Barman; G L Gebber
Journal:  J Pharmacol Exp Ther       Date:  1979-04       Impact factor: 4.030

8.  The antihypertensive effect of lexotan (bromazepam)- a new benzodiazepine derivative.

Authors:  H Pozenel; A Bückert; R Amrein
Journal:  Int J Clin Pharmacol Biopharm       Date:  1977-01

9.  Possible involvement of GABA mechanisms in central cardiovascular and respiratory control. Studies on the interaction between diazepam, picrotoxin and clonidine.

Authors:  P Bolme; K Fuxe
Journal:  Med Biol       Date:  1977-12

10.  Sedative and cardiovascular effects of clonidine and nitrazepam.

Authors:  V Hossmann; T J Maling; C A Hamilton; J L Reid; C T Dollery
Journal:  Clin Pharmacol Ther       Date:  1980-08       Impact factor: 6.875

View more
  3 in total

1.  Intravenous alprazolam challenge in normal subjects. Biochemical, cardiovascular, and behavioral effects.

Authors:  E D Risby; J K Hsiao; R N Golden; W Z Potter
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  The stress-induced reduction in monoamine oxidase (MAO) A activity is reversed by benzodiazepines: role of peripheral benzodiazepine receptors.

Authors:  I Armando; A P Lemoine; E T Segura; M B Barontini
Journal:  Cell Mol Neurobiol       Date:  1993-12       Impact factor: 5.046

3.  Changes in noradrenaline plasma levels and behavioural responses induced by benzodiazepine agonists with the benzodiazepine antagonist Ro 15-1788.

Authors:  T Duka; M Ackenheil; J Noderer; A Doenicke; R Dorow
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.